NCT03591510
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03591510
Title A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child
Covered Countries TUR | SVN | POL | ITA | DEU | CZE

Facility Status City State Zip Country Details
Novartis Investigative Site Prague 150 06 Czechia Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Pavia PV 27100 Italy Details
Novartis Investigative Site Roma RM 00165 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Napoli 80122 Italy Details
Novartis Investigative Site Osaka 534-0021 Japan Details
Novartis Investigative Site Amman 11941 Jordan Details
Novartis Investigative Site Krakow 30-663 Poland Details
Novartis Investigative Site Moscow 117198 Russia Details
Novartis Investigative Site Ljubljana 1000 Slovenia Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Adana Adana 1330 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field